Literature DB >> 6819381

Parathyroid function in persistent hyperparathyroidism: relationship to gland size.

D A McCarron, R S Muther, B Lenfesty, W M Bennett.   

Abstract

The release of parathyroid hormone in experimental animals is related inversely to the plasma calcium concentration. The relevance, though, of these observations to the dynamics of parathyroid function in normal and hyperparathyroid humans is uncertain. We assessed the in vivo parathyroid hormone response to changes in extracellular calcium in 8 normal subjects and 15 patients with persistent hyperparathyroidism following renal transplantation. In 12 hyperparathyroid patients, the hormone response was related to their total gland size measured at the time of their parathyroidectomy. Plasma ionized calcium, magnesium, and parathyroid hormone concentrations were measured in the basal state and during a 2-hr infusion of EDTA (50 mg/kg), and a 4-hr calcium infusion (15 mg/kg). The parathyroid function curves of both groups of subjects (P less than 0.001) fit a log-linear relationship. The slopes of the respective parathyroid function curves were similar, although the hyperparathyroid curve was shifted to the right (P less than 0.0001). Gland size was not predicted by basal PTH levels; however, it did correlate with changes in parathyroid hormone induced by EDTA (P less than 0.001) and calcium (P less than 0.001). We conclude that the in vivo sensitivity of hyperplastic glands to changes in plasma calcium is maintained. The excessive secretion of immunoreactive parathyroid hormone in chief cell hyperplasia primarily reflects total gland mass. Our results indicate that the assessment of the dynamics of parathyroid response, rather than measurements of static plasma parathyroid hormone and calcium concentrations, should be further investigated as a more rational application of radioimmunoassays in the evaluation of the parathyroid axis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819381     DOI: 10.1038/ki.1982.227

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Changes in bone mineral metabolism parameters, including FGF23, after discontinuing cinacalcet at kidney transplantation.

Authors:  Xoana Barros; David Fuster; Raphael Paschoalin; Federico Oppenheimer; Domenico Rubello; Pilar Perlaza; Francesca Pons; Jose V Torregrosa
Journal:  Endocrine       Date:  2014-08-26       Impact factor: 3.633

2.  Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2.

Authors:  Irina V Grigorieva; Samantha Mirczuk; Katherine U Gaynor; M Andrew Nesbit; Elena F Grigorieva; Qiaozhi Wei; Asif Ali; Rebecca J Fairclough; Joanna M Stacey; Michael J Stechman; Radu Mihai; Dorota Kurek; William D Fraser; Tertius Hough; Brian G Condie; Nancy Manley; Frank Grosveld; Rajesh V Thakker
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

3.  Set point of calcium in severe secondary hyperparathyroidism is altered and does not change after successful kidney transplantation.

Authors:  Jose-Vicente Torregrosa; David Fuster; Carlos Eduardo Duran; Federico Oppenheimer; África Muxí; Domenico Rubello; Francesca Pons; Jose Maria Campistol
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

4.  Graft-dependent renal hyperparathyroidism despite successful kidney transplantation.

Authors:  K Schlosser; M Rothmund; K Maschuw; P J Barth; T P Vahl; K L Suchan; E Domínguez Fernández
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

5.  Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children.

Authors:  J A Ramirez; W G Goodman; C Menezes; G V Segre; I B Salusky
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

6.  Hyperparathyroidism after kidney transplantation: a retrospective case controlled study.

Authors:  J Vlcek; U Binswanger; G Keusch; J Záruba
Journal:  Klin Wochenschr       Date:  1991-09-16

7.  Clinical impact of hypercalcemia in kidney transplant.

Authors:  Piergiorgio Messa; Cosimo Cafforio; Carlo Alfieri
Journal:  Int J Nephrol       Date:  2011-06-22

8.  Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients.

Authors:  Marius C Florescu; Km Monirul Islam; Troy J Plumb; Sara Smith-Shull; Jennifer Nieman; Prasanti Mandalapu
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-05-14

9.  Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease.

Authors:  Steven Cheng; Daniel Coyne
Journal:  Ther Clin Risk Manag       Date:  2006-09       Impact factor: 2.423

10.  Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Li Fang; Bing Tang; Dawei Hou; Meijuan Meng; Mingxia Xiong; Junwei Yang
Journal:  BMC Nephrol       Date:  2015-06-10       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.